← Leaderboards
Crystal M Fuller
New York Academy Of Medicine
$12,998,257
Attributed
$17,659,867
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,471,163 · 11
AHRQ$1,188,704 · 1
By mechanism
R01$12,072,416 · 5
R25$1,397,920 · 1
R18$1,188,704 · 1
R34$1,134,254 · 2
RC1$999,881 · 1
R21$866,692 · 2
Top collaborators
- Helen-Maria Lekas10 shared
- Babak Tofighi8 shared
- Michael Kobor5 shared
- Kerstin Pahl5 shared
- Ana F Abraido-Lanza3 shared
- Silvia Amesty2 shared
Most similar at New York Academy Of Medicine
Same institution · by research overlap
- John J. Chin$4,440,776
- David H Vlahov$30,228,718
- Victoria Frye$5,622,395
- Silvia Amesty$1,582,111
Others in their field
Top investigators on “Surveys”
- David R. Weir · University Of Michigan At Ann Arbor$412,563,064
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$307,909,508
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- Steven M Kahn · Association Of Universities For Research In Astronomy, Inc.$147,577,053
Research focus
SurveysInterviewCommunitiesProgramsInnovationBaseServicesDesignNew YorkPublic Health Medicine (Field)SiteSyringesPharmacy FacilityAttitudeDrug UsageAccountingPharmacistsEnrollmentPharmaceutical ServicesPharmaceutical PreparationsLinkResearch PersonnelAreaPersons
Grant awards (45)
Life-Course Adversity and Other Determinants of Stress Regulation & Epigenetic Aging in Midlife Adults$591,751
R01 · FY2025 · AG
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform$280,478
R34 · FY2025 · DA
Life-Course Adversity and Other Determinants of Stress Regulation & Epigenetic Aging in Midlife Adults$30,689
R01 · FY2025 · AG
Structural Adversity and Life-Course Social Determinants of Stress Regulation and Epigenetic Aging in Midlife Adults$652,615
R01 · FY2024 · AG
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$564,435
R18 · FY2024 · HS
Addressing racial disparities in opioid overdose deaths using an open source peer recovery coach training and multimodal mobile health platform$225,981
R34 · FY2024 · DA
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$168,781
R34 · FY2024 · DA · contact PI
Structural Adversity and Life-Course Social Determinants of Stress Regulation and Epigenetic Aging in Midlife Adults$678,125
R01 · FY2023 · AG
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$548,486
R18 · FY2023 · HS
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$284,124
R34 · FY2023 · DA · contact PI
Leveraging social determinants via artificial intelligence and peer coaching to address racial disparities in primary care among people who use opioids$75,783
R18 · FY2023 · HS
Structural Adversity and Life-Course Social Determinants of Stress Regulation and Epigenetic Aging in Midlife Adults$686,543
R01 · FY2022 · AG
Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services$174,890
R34 · FY2022 · DA · contact PI
Feasibility of a pharmacy-based overdose prevention program in rural/suburban NY$224,183
R21 · FY2021 · DA · contact PI
Feasibility of a pharmacy-based overdose prevention program in rural/suburban NY$202,509
R21 · FY2020 · DA · contact PI
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$641,700
R01 · FY2014 · DA
IMSD at Columbia's Mailman School of Public Health$471,474
R25 · FY2014 · GM
Exploratory study of drug user health-related internet and mobile technology use$240,000
R21 · FY2014 · DA
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$633,065
R01 · FY2013 · DA · contact PI
IMSD at Columbia's Mailman School of Public Health$454,972
R25 · FY2013 · GM
Exploratory study of drug user health-related internet and mobile technology use$200,000
R21 · FY2013 · DA · contact PI
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$14,400
R01 · FY2013 · DA · contact PI
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$679,575
R01 · FY2012 · DA · contact PI
IMSD at Columbia's Mailman School of Public Health$471,474
R25 · FY2012 · GM
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$78,269
R01 · FY2012 · DA · contact PI
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$699,076
R01 · FY2011 · DA · contact PI
Post exposure prophylaxis among IDU syringe customers-Pharmacy pilot intervention$739,299
R01 · FY2010 · DA · contact PI
Development of Behavioral and Social Interventions that Reduce Stigma and Improve$499,997
RC1 · FY2010 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$465,819
R01 · FY2010 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$173,773
R01 · FY2010 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$76,576
R01 · FY2010 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$684,433
R01 · FY2009 · DA · contact PI
Development of Behavioral and Social Interventions that Reduce Stigma and Improve$499,884
RC1 · FY2009 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$437,405
R01 · FY2009 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$7,480
R01 · FY2009 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$689,300
R01 · FY2008 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$393,799
R01 · FY2008 · DA · contact PI
Pharmacy Referral Intervention: IDU Access to Services$688,457
R01 · FY2007 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$448,410
R01 · FY2007 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$413,867
R01 · FY2006 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$45,885
R01 · FY2006 · DA · contact PI
Social Predictors for Transition into Injection Drug Use$426,966
R01 · FY2005 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$387,127
R01 · FY2004 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$93,175
R01 · FY2004 · DA
PREVENTION OF HIV AMONG NEW IDUS AND NON-IDUS IN HARLEM$514,837
R01 · FY2003 · DA